vs
Cooper Companies (The)（COO）与美泰（MAT）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是美泰的1.2倍（$1.1B vs $862.2M），Cooper Companies (The)净利率更高（7.9% vs 7.1%，领先0.9%），Cooper Companies (The)同比增速更快（4.6% vs 4.3%），Cooper Companies (The)自由现金流更多（$149.9M vs $-88.1M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs -10.6%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
美泰是美国知名玩具及娱乐企业，旗下影视制作部门美泰影业运营时间为2018年9月6日至2025年6月2日。其前身为2013年10月16日成立的美泰Playground Productions，更早可追溯至美泰娱乐、美泰工作室等集团原有娱乐业务品牌。
COO vs MAT — 直观对比
营收规模更大
COO
是对方的1.2倍
$862.2M
营收增速更快
COO
高出0.3%
4.3%
净利率更高
COO
高出0.9%
7.1%
自由现金流更多
COO
多$238.0M
$-88.1M
两年增速更快
COO
近两年复合增速
-10.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $862.2M |
| 净利润 | $84.6M | $61.0M |
| 毛利率 | 61.1% | 44.9% |
| 营业利润率 | 13.2% | — |
| 净利率 | 7.9% | 7.1% |
| 营收同比 | 4.6% | 4.3% |
| 净利润同比 | -28.0% | 251.4% |
| 每股收益（稀释后） | $0.42 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOMAT
| Q1 26 | — | $862.2M | ||
| Q4 25 | $1.1B | $1.8B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $964.7M | $826.6M | ||
| Q4 24 | $1.0B | $1.6B | ||
| Q3 24 | $1.0B | $1.8B | ||
| Q2 24 | $942.6M | $1.1B |
净利润COOMAT
| Q1 26 | — | $61.0M | ||
| Q4 25 | $84.6M | $106.2M | ||
| Q3 25 | $98.3M | $278.4M | ||
| Q2 25 | $87.7M | $53.4M | ||
| Q1 25 | $104.3M | $-40.3M | ||
| Q4 24 | $117.5M | $140.9M | ||
| Q3 24 | $104.7M | $372.4M | ||
| Q2 24 | $88.9M | $56.9M |
毛利率COOMAT
| Q1 26 | — | 44.9% | ||
| Q4 25 | 61.1% | 45.9% | ||
| Q3 25 | 65.3% | 50.0% | ||
| Q2 25 | 67.8% | 50.9% | ||
| Q1 25 | 68.4% | 49.4% | ||
| Q4 24 | 66.5% | 50.7% | ||
| Q3 24 | 66.1% | 53.1% | ||
| Q2 24 | 67.0% | 49.2% |
营业利润率COOMAT
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | 8.0% | ||
| Q3 25 | 16.6% | 21.9% | ||
| Q2 25 | 18.4% | 7.7% | ||
| Q1 25 | 18.9% | -6.4% | ||
| Q4 24 | 19.5% | 9.6% | ||
| Q3 24 | 19.2% | 26.5% | ||
| Q2 24 | 17.2% | 7.7% |
净利率COOMAT
| Q1 26 | — | 7.1% | ||
| Q4 25 | 7.9% | 6.0% | ||
| Q3 25 | 9.3% | 16.0% | ||
| Q2 25 | 8.7% | 5.2% | ||
| Q1 25 | 10.8% | -4.9% | ||
| Q4 24 | 11.5% | 8.6% | ||
| Q3 24 | 10.4% | 20.2% | ||
| Q2 24 | 9.4% | 5.3% |
每股收益（稀释后）COOMAT
| Q1 26 | — | $0.20 | ||
| Q4 25 | $0.42 | $0.32 | ||
| Q3 25 | $0.49 | $0.88 | ||
| Q2 25 | $0.44 | $0.16 | ||
| Q1 25 | $0.52 | $-0.12 | ||
| Q4 24 | $0.59 | $0.40 | ||
| Q3 24 | $0.52 | $1.09 | ||
| Q2 24 | $0.44 | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $866.0M |
| 总债务越低越好 | $2.5B | $2.3B |
| 股东权益账面价值 | $8.2B | $2.1B |
| 总资产 | $12.4B | $6.3B |
| 负债/权益比越低杠杆越低 | 0.30× | 1.11× |
8季度趋势，按日历期对齐
现金及短期投资COOMAT
| Q1 26 | — | $866.0M | ||
| Q4 25 | $110.6M | $1.2B | ||
| Q3 25 | $124.9M | $691.9M | ||
| Q2 25 | $116.2M | $870.5M | ||
| Q1 25 | $100.9M | $1.2B | ||
| Q4 24 | $107.6M | $1.4B | ||
| Q3 24 | $109.7M | $723.5M | ||
| Q2 24 | $112.4M | $722.4M |
总债务COOMAT
| Q1 26 | — | $2.3B | ||
| Q4 25 | $2.5B | $2.3B | ||
| Q3 25 | $2.4B | $2.3B | ||
| Q2 25 | $2.5B | $2.3B | ||
| Q1 25 | $2.5B | $2.3B | ||
| Q4 24 | $2.6B | $2.3B | ||
| Q3 24 | $2.6B | $2.3B | ||
| Q2 24 | $2.7B | $2.3B |
股东权益COOMAT
| Q1 26 | — | $2.1B | ||
| Q4 25 | $8.2B | $2.2B | ||
| Q3 25 | $8.4B | $2.3B | ||
| Q2 25 | $8.3B | $2.2B | ||
| Q1 25 | $8.1B | $2.1B | ||
| Q4 24 | $8.1B | $2.3B | ||
| Q3 24 | $7.9B | $2.3B | ||
| Q2 24 | $7.8B | $2.0B |
总资产COOMAT
| Q1 26 | — | $6.3B | ||
| Q4 25 | $12.4B | $6.6B | ||
| Q3 25 | $12.4B | $6.6B | ||
| Q2 25 | $12.4B | $6.2B | ||
| Q1 25 | $12.2B | $6.2B | ||
| Q4 24 | $12.3B | $6.5B | ||
| Q3 24 | $12.1B | $6.5B | ||
| Q2 24 | $12.0B | $5.9B |
负债/权益比COOMAT
| Q1 26 | — | 1.11× | ||
| Q4 25 | 0.30× | 1.04× | ||
| Q3 25 | 0.29× | 1.03× | ||
| Q2 25 | 0.30× | 1.08× | ||
| Q1 25 | 0.31× | 1.10× | ||
| Q4 24 | 0.32× | 1.03× | ||
| Q3 24 | 0.33× | 1.01× | ||
| Q2 24 | 0.34× | 1.18× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | — |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $-88.1M |
| 自由现金流率自由现金流/营收 | 14.1% | -10.2% |
| 资本支出强度资本支出/营收 | 9.2% | 7.6% |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COOMAT
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $796.6M | ||
| Q3 25 | $261.4M | $72.0M | ||
| Q2 25 | $96.2M | $-300.1M | ||
| Q1 25 | $190.6M | $24.8M | ||
| Q4 24 | $268.1M | $862.1M | ||
| Q3 24 | $207.5M | $155.8M | ||
| Q2 24 | $111.0M | $-252.9M |
自由现金流COOMAT
| Q1 26 | — | $-88.1M | ||
| Q4 25 | $149.9M | — | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $101.2M | — | ||
| Q4 24 | $128.1M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $36.9M | — |
自由现金流率COOMAT
| Q1 26 | — | -10.2% | ||
| Q4 25 | 14.1% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 3.9% | — |
资本支出强度COOMAT
| Q1 26 | — | 7.6% | ||
| Q4 25 | 9.2% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 7.9% | — |
现金转化率COOMAT
| Q1 26 | — | — | ||
| Q4 25 | 2.93× | 7.50× | ||
| Q3 25 | 2.66× | 0.26× | ||
| Q2 25 | 1.10× | -5.62× | ||
| Q1 25 | 1.83× | — | ||
| Q4 24 | 2.28× | 6.12× | ||
| Q3 24 | 1.98× | 0.42× | ||
| Q2 24 | 1.25× | -4.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
MAT
暂无分部数据
